BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32311644)

  • 1. Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations.
    Libert DM; Prayson RA
    Ann Diagn Pathol; 2020 Jun; 46():151516. PubMed ID: 32311644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCE1 mutation screening in classification of clear cell meningiomas.
    Smith MJ; Ahn S; Lee JI; Bulman M; Plessis DD; Suh YL
    Histopathology; 2017 Apr; 70(5):814-820. PubMed ID: 27891692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCE1 mutations in pediatric clear cell meningioma: case report.
    Evans LT; Van Hoff J; Hickey WF; Smith MJ; Evans DG; Newman WG; Bauer DF
    J Neurosurg Pediatr; 2015 Sep; 16(3):296-300. PubMed ID: 26114992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
    Smith MJ; Wallace AJ; Bennett C; Hasselblatt M; Elert-Dobkowska E; Evans LT; Hickey WF; van Hoff J; Bauer D; Lee A; Hevner RF; Beetz C; du Plessis D; Kilday JP; Newman WG; Evans DG
    J Pathol; 2014 Dec; 234(4):436-40. PubMed ID: 25143307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.
    Tauziede-Espariat A; Parfait B; Besnard A; Lacombe J; Pallud J; Tazi S; Puget S; Lot G; Terris B; Cohen J; Vidaud M; Figarella-Branger D; Monnien F; Polivka M; Adle-Biassette H; Varlet P
    Brain Pathol; 2018 Jul; 28(4):466-474. PubMed ID: 28474749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case.
    Raffalli-Ebezant H; Rutherford SA; Stivaros S; Kelsey A; Smith M; Evans DG; Kilday JP
    Childs Nerv Syst; 2015 Mar; 31(3):441-7. PubMed ID: 25249420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCE1-related meningiomas: A clear example of cancer predisposing syndrome.
    Fiorentini E; Giunti L; Di Rita A; Peraio S; Fonte C; Caporalini C; Buccoliero AM; Censullo ML; Gori G; Noris A; Pasquariello R; Battini R; Pavone R; Giordano F; Giglio S; Rinaldi B
    Eur J Med Genet; 2023 Jul; 66(7):104784. PubMed ID: 37164167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of genetic counseling and screening for people with pathogenic SMARCE1 variants: A family study.
    Shoakazemi A; Hewitt A; Smith MJ; du Plessis D; Thomas O; Stivaros SM; Deniz K; Hammerbeck-Ward C; Rutherford SA; King AT; Evans DG
    Am J Med Genet A; 2021 Feb; 185(2):561-565. PubMed ID: 33185983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline and somatic mutations in meningiomas.
    Smith MJ
    Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
    Sievers P; Sill M; Blume C; Tauziede-Espariat A; Schrimpf D; Stichel D; Reuss DE; Dogan H; Hartmann C; Mawrin C; Hasselblatt M; Stummer W; Schick U; Hench J; Frank S; Ketter R; Schweizer L; Schittenhelm J; Puget S; Brandner S; Jaunmuktane Z; Küsters B; Abdullaev Z; Pekmezci M; Snuderl M; Ratliff M; Herold-Mende C; Unterberg A; Aldape K; Ellison DW; Wesseling P; Reifenberger G; Wick W; Perry A; Varlet P; Pfister SM; Jones DTW; von Deimling A; Sahm F;
    Acta Neuropathol; 2021 Feb; 141(2):281-290. PubMed ID: 33319313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening.
    Gerkes EH; Fock JM; den Dunnen WF; van Belzen MJ; van der Lans CA; Hoving EW; Fakkert IE; Smith MJ; Evans DG; Olderode-Berends MJ
    Neurogenetics; 2016 Apr; 17(2):83-9. PubMed ID: 26803492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States.
    Navalkele P; Guzman M; Kirby A; Pinz H; Kemp J
    J Neuropathol Exp Neurol; 2020 Nov; 79(11):1250-1252. PubMed ID: 33085974
    [No Abstract]   [Full Text] [Related]  

  • 13. Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.
    Smith MJ; O'Sullivan J; Bhaskar SS; Hadfield KD; Poke G; Caird J; Sharif S; Eccles D; Fitzpatrick D; Rawluk D; du Plessis D; Newman WG; Evans DG
    Nat Genet; 2013 Mar; 45(3):295-8. PubMed ID: 23377182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of SMARCE1 in the diagnosis of clear cell meningioma].
    Zhang L; Yao ZG; Lian F; Wang DZ; Chen YP; Cai SS; Zhang S; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):234-238. PubMed ID: 32187894
    [No Abstract]   [Full Text] [Related]  

  • 15. Venous Anatomy Influence on the Approach Selection of a Petroclival Clear Cell Meningioma With Associated Multiple Spinal Meningiomas: 2-Dimensional Operative Video.
    Essayed WIBN; Mooney MA; Al-Mefty O
    Oper Neurosurg (Hagerstown); 2021 May; 20(6):E426-E427. PubMed ID: 33928378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary clear cell meningiomas in a single family: three-cases report.
    Inoue T; Shitara S; Ozeki M; Nozawa A; Fukao T; Fukushima T
    Acta Neurochir (Wien); 2018 Dec; 160(12):2321-2325. PubMed ID: 30421029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.
    Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA
    Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic landscape of meningioma.
    Yuzawa S; Nishihara H; Tanaka S
    Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.